8-K: Concentrix Reports Strong Q4 and Fiscal Year 2024 Results, Announces Increased Share Repurchase Program
Earnings Release
Concentrix Corporation announces its Q4 and fiscal year 2024 results, highlighting revenue growth, shareholder returns, and the introduction of 2025 guidance with expected revenue growth and margin expansion.
Summary
- Concentrix Corporation reported a 9.7% year-over-year increase in revenue for the fourth quarter of fiscal year 2024, reaching $2,448.0 million.
- For the full fiscal year 2024, revenue increased by 35.2% year-over-year to $9,618.9 million.
- The company's operating income for Q4 2024 was $144.5 million, while non-GAAP operating income was $346.7 million.
- Adjusted EBITDA for Q4 2024 was $402.9 million.
- Diluted earnings per share (EPS) for Q4 2024 was $1.72, and non-GAAP diluted EPS was $3.26.
- For the full fiscal year, diluted EPS was $3.71, and non-GAAP diluted EPS was $11.42.
- Concentrix returned $220 million to shareholders in fiscal year 2024 through share repurchases and dividends.
- The company's Board of Directors has authorized an increase in the share repurchase program to $600 million.
- First quarter fiscal 2025 revenue is expected to be between $2.355 billion and $2.370 billion.
- Full year fiscal 2025 revenue is projected to be between $9.470 billion and $9.610 billion.
- The company anticipates generating $625 million to $650 million of adjusted free cash flow in fiscal year 2025.
Sentiment
Score: 7
Explanation: The sentiment is positive due to strong revenue growth, shareholder returns, and optimistic future guidance. However, there are some concerns about decreased operating income and diluted earnings per share.
Positives
- Concentrix achieved revenue growth at the high end of its previous guidance range for the quarter.
- The company returned a significant amount of capital to shareholders through share repurchases and dividends.
- The introduction of 2025 guidance indicates expected revenue growth, margin expansion, and free cash flow expansion.
- The company is gaining market traction with its new iX GenAI productivity applications.
- The Board of Directors increased the share repurchase authorization to $600 million.
Negatives
- Operating income decreased by 19.9% for the three months ended November 30, 2024.
- Operating income decreased by 9.8% for the fiscal year ended November 30, 2024.
- Diluted earnings per common share decreased by 34.9% for the fiscal year ended November 30, 2024.
- Non-GAAP diluted earnings per common share decreased by 0.3% for the fiscal year ended November 30, 2024.
Risks
- The company's forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
- These risks include general economic conditions, cyberattacks, new and emerging technologies, and competitive conditions.
- The company also faces risks related to client demand, changes in laws and regulations, and the ability to retain key personnel.
Future Outlook
Concentrix expects first quarter fiscal 2025 revenue to be between $2.355 billion and $2.370 billion and full year fiscal 2025 revenue to be between $9.470 billion and $9.610 billion. The company also expects to generate $625 million to $650 million of adjusted free cash flow in fiscal year 2025.
Management Comments
- Chris Caldwell, Concentrix President and CEO, stated that the company continues to achieve strong results across key areas of growth while repurchasing shares, reducing leverage, and supporting the dividend.
- He also mentioned that the company's investments in its GenAI product suite have generated more than a dozen wins shortly after launch.
- Caldwell expressed delight with the company's strategic position and opportunities for ongoing growth, margin, and free cash flow in 2025.
Industry Context
Concentrix operates in the global technology and services industry, providing end-to-end solutions to over 2,000 clients. The company's focus on generative AI and digital operations aligns with the industry's increasing emphasis on technology-driven customer experience and business process optimization.
Comparison to Industry Standards
- Concentrix's revenue growth of 35.2% for fiscal year 2024 is significantly higher than the average growth rate for the IT services industry, which is estimated to be around 5-7%.
- Companies like Accenture and Tata Consultancy Services (TCS) have reported revenue growth in the range of 8-12% for their most recent fiscal years.
- Concentrix's adjusted EBITDA margin of 16.2% is comparable to industry leaders like Accenture, which typically reports EBITDA margins in the range of 15-17%.
- The company's focus on share repurchases and dividends is also in line with industry trends, as many IT services companies are returning capital to shareholders through these mechanisms.
Stakeholder Impact
- Shareholders will benefit from the increased share repurchase program and continued dividend payments.
- Employees may benefit from the company's growth and expansion plans.
- Customers will benefit from the company's focus on innovation and technology-driven solutions.
Next Steps
- The company will host a conference call for investors to review its fourth quarter and full year fiscal 2024 financial results.
- The company will continue to execute its plan for growth and market expansion.
- The company will focus on delivering value to shareholders through share repurchases and dividends.
Key Dates
| Date | Description |
|---|---|
| November 30, 2024 | End of fiscal fourth quarter and fiscal year 2024 |
| November 5, 2024 | Company paid a $0.33275 per share quarterly dividend |
| January 15, 2025 | Date of the earnings release and 8-K filing |
| January 31, 2025 | Record date for the next quarterly dividend |
| February 11, 2025 | Payment date for the next quarterly dividend of $0.33275 per share |
| February 28, 2025 | End of first quarter fiscal year 2025 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.